22 Results

People

  1. Landgren
    Landgren
  2. Landau
    Landau
  3. Hassoun
    Hassoun
  4. Hu
    Hu
  5. Liu
    Liu
  6. Majumdar
    Majumdar
  7. Chapman-Lim
    Chapman-Lim
  8. Giralt
    Giralt
  9. Hultcrantz
    Hultcrantz
  10. Korde
    Korde

Groups

  1. Department of Medicine (11)
  2. Center for Hematologic Malignancies (9)
  3. Hematologic Malignancies, Division of (9)
  4. Myeloma (7)
  5. Survivorship Research (7)
  6. Hematologic Malignancies Research (5)
  7. Bone Marrow Transplant (4)
  8. Department of Pathology and Laboratory Medicine (4)
  9. GSK Faculty (4)
  10. Sloan Kettering Institute Faculty (3)
  1. "m protein"
Formats
  1. Journal Article (21)
  2. Review (1)
Groups
  1. Department of Medicine (11)
  2. Center for Hematologic Malignancies (9)
  3. Hematologic Malignancies, Division of (9)
  4. Myeloma (7)
  5. Survivorship Research (7)
  6. Hematologic Malignancies Research (5)

More Groups

People
  1. Carl Landgren (5)
  2. Heather Landau (4)
  3. Aizhuo Liu (3)
  4. Ananya Majumdar (3)
  5. Hani Hassoun (3)
  6. Weidong Hu (3)

More People

Years
  1. 2025 (2)
  2. 2023 (1)
  3. 2020 (4)
  4. 2018 (1)
  5. 2015 (2)
  6. 2014 (2)

More Years

Publications
  1. Journal of Biomolecular NMR (3)
  2. British Journal of Haematology (2)
  3. Journal of the National Comprehensive Cancer Network (2)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Blood (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. Springer (3)
  3. American Association for Cancer Research (2)
  4. Elsevier Science, Inc. (2)
  5. Harborside Press (2)
  6. John Wiley & Sons (2)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting progression events in multiple myeloma from routine blood work
    Journal Article

    Ferle, M.; Grieb, N.; Kreuz, M.; Ader, J.; Goldschmidt, H.; Mai, E. K.; Bertsch, U.; Platzbecker, U.; Neumuth, T.; Reiche, K.; more...
    npj Digital Medicine (2025)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study
    Journal Article

    Rögnvaldsson, S.; Gasparini, A.; Thorsteinsdottir, S.; Sverrisdottir, I.; Eythorsson, E.; Long, T. E.; Palmason, R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): Final analysis of an open-label, randomised, phase 2 trial
    Journal Article

    Voorhees, P. M.; Sborov, D. W.; Laubach, J.; Kaufman, J. L.; Reeves, B.; Rodriguez, C.; Chari, A.; Silbermann, R.; Costa, L. J.; Anderson, L. D. Jr; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
    Journal Article

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Lu, S.; Shah, U.; Hassoun, H.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Mass spectrometry-based method targeting Ig variable regions for assessment of minimal residual disease in multiple myeloma
    Journal Article

    Martins, C. O.; Huet, S.; Yi, S. S.; Ritorto, M. S.; Landgren, O.; Dogan, A.; Chapman, J. R.
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Bendamustine with dexamethasone in relapsed/ refractory systemic light-chain amyloidosis: Results of a phase II study
    Journal Article

    Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Osman, K.; Pan, S.; Bhutani, D.; Pregja, S.; Sanchorawala, V.; Landau, H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Tracking of low disease burden in multiple myeloma: Using mass spectrometry assays in peripheral blood
    Review

    Chapman, J. R.; Thoren, K. L.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save
  • Multiple myeloma, version 2.2016
    Journal Article

    Anderson, K. C.; Alsina, M.; Atanackovic, D.; Biermann, J. S.; Chandler, J. C.; Costello, C.; Djulbegovic, B.; Fung, H. C.; Gasparetto, C.; Godby, K.; more...
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • Second autologous stem cell transplant: An effective therapy for relapsed multiple myeloma
    Journal Article

    Singh Abbi, K. K.; Zheng, J.; Devlin, S. M.; Giralt, S.; Landau, H.
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save